Karen Bruckmann

Karen Bruckmann is a seasoned clinical operations professional with extensive experience in managing global clinical trials. Currently serving as the Director of Global Clinical Operations at Novocure since November 2022, Karen leads operational execution for clinical studies. Previous roles include Senior Director of Clinical Operations at Aceragen, Clinical Operations Leader at AZAFAROS B.V., and Director of Clinical Operations at both Enzyvant and Roivant Sciences. With a strong foundation at Covance, where Karen was Associate Director of Clinical Operations for Early Clinical Development, responsibilities included multinational strategic leadership and overseeing early-phase trial monitoring. Karen Bruckmann holds an MSc in Clinical Research from Cardiff University and a Staatsexamen from Berufskolleg, NTA Isny.